
Relugolix (Relugonat) is a hormone therapy used to treat adult men with advanced prostate cancer. It belongs to a group of medicines called GnRH receptor antagonists and works by lowering testosterone levels, which can help slow the growth of prostate cancer cells. It is taken orally as prescribed by an oncologist.
| Generic Name | Relugolix |
| Manufacturer | Natco |
| Packing | 30 Tablets |
| Prescribed For | Advanced prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Relugolix blocks GnRH receptors in the pituitary gland, reducing the release of hormones that stimulate testosterone production in the testes. Lower testosterone levels can help limit the growth and activity of prostate cancer cells that depend on this hormone.